Mark Daniels, PhD

Photo of Mark Daniels, PhD

Molecular Microbiology and Immunology

Surgery

Associate Professor
Director of Graduate Studies
Molecular Pathogenesis and Therapeutics Graduate Program

573-884-1659

Profile

A healthy individual can mount an immune response to pathogens and tumors while avoiding an autoimmune attack on normal tissues. Dr. Daniels' lab studies how signal transduction pathways regulate lymphocyte development and activation. He is exploring how deregulation of these signaling pathways leads to the development of hematological cancers. His multidisciplinary collaborative team is applying these findings to develop new anti-leukemia/lymphoma drugs and improved immunotherapy-based treatments of multiple forms of cancer. Another important goal is to elucidate the mechanisms that regulate the balance between immune protection and tolerance. Dr. Daniels expects this work will lead to improved treatment of autoimmunity and infectious disease.

Lab members

Academic Information

Associate Professor
Director of Graduate Studies
Molecular Pathogenesis and Therapeutics Graduate Program

Office

NW301 Medical Sciences Bldg.
Columbia, MO 65212
United States

P. 573-884-1659

Research Interests

  • T and B cell biology
  • Tumor immunotherapy
  • Leukemia
  • Lymphoma
  • Autoimmunity
  • Immune Response to Pathogens
  • Signal Transduction
  • Biochemistry
  • Immunology
  • Drug Development

Areas of Expertise

  • T and B cell development and activation
  • T cell engineering
  • Lymphocyte signaling, oncology and cell biology

Education & Training

Post-Graduate School

2002, PhD, University of Minnesota

Publications

Download All Publications Download